User profiles for "author:Holly Lindsay"

Lindsay Holly

Marquette University
Verified email at marquette.edu
Cited by 380

Evidence-base update for parenting stress measures in clinical samples

LE Holly, AR Fenley, TK Kritikos… - Journal of Clinical …, 2019 - Taylor & Francis
Parenting stress is relevant to the development, maintenance, and amelioration of youth
mental, emotional, and behavioral health issues. This Evidence Base Update evaluates the …

Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working …

HB Lindsay, M Massimino, S Avula, S Stivaros… - The Lancet …, 2022 - thelancet.com
Response criteria for paediatric intracranial ependymoma vary historically and across
different international cooperative groups. The Response Assessment in the Pediatric Neuro …

[PDF][PDF] Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design

JL Rokita, KS Rathi, MF Cardenas, KA Upton… - Cell reports, 2019 - cell.com
Accelerating cures for children with cancer remains an immediate challenge as a result of
extensive oncogenic heterogeneity between and within histologies, distinct molecular …

[HTML][HTML] The children's brain tumor network (CBTN)-Accelerating research in pediatric central nervous system tumors through collaboration and open science

JV Lilly, JL Rokita, JL Mason, T Patton, S Stefankiewiz… - Neoplasia, 2023 - Elsevier
Pediatric brain tumors are the leading cause of cancer-related death in children in the
United States and contribute a disproportionate number of potential years of life lost …

[PDF][PDF] A C19MC-LIN28A-MYCN oncogenic circuit driven by hijacked super-enhancers is a distinct therapeutic vulnerability in ETMRs: a lethal brain tumor

P Sin-Chan, I Mumal, T Suwal, B Ho, X Fan, I Singh… - Cancer cell, 2019 - cell.com
Embryonal tumors with multilayered rosettes (ETMRs) are highly lethal infant brain cancers
with characteristic amplification of Chr19q13. 41 miRNA cluster (C19MC) and enrichment of …

Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group

LM Hoffman, C Jaimes, K Mankad, DM Mirsky… - Neuro …, 2023 - academic.oup.com
Background Craniopharyngioma is a histologically benign tumor of the suprasellar region
for which survival is excellent but quality of life is often poor secondary to functional deficits …

Genetics of common pediatric brain tumors

F Malbari, H Lindsay - Pediatric Neurology, 2020 - Elsevier
Central nervous system tumors are the most common solid tumors in pediatrics and
represent the largest cause of childhood cancer-related mortality. Improvements have …

Systems biology–based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma

L Huang, S Garrett Injac, K Cui, F Braun, Q Lin… - Science translational …, 2018 - science.org
Medulloblastoma (MB) is the most common malignant brain tumor of childhood. Although
outcomes have improved in recent decades, new treatments are still needed to improve …

[HTML][HTML] Epigenetic alterations of repeated relapses in patient-matched childhood ependymomas

S Zhao, J Li, H Zhang, L Qi, Y Du, M Kogiso… - Nature …, 2022 - nature.com
Recurrence is frequent in pediatric ependymoma (EPN). Our longitudinal integrated analysis
of 30 patient-matched repeated relapses (3.67±1.76 times) over 13 years (5.8±3.8) reveals …

[HTML][HTML] c-Fos over-expression promotes radioresistance and predicts poor prognosis in malignant glioma

ZG Liu, G Jiang, J Tang, H Wang, G Feng, F Chen… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Abstract c-Fos is a major component of activator protein (AP)-1 complex. It has been
implicated in cell differentiation, proliferation, angiogenesis, invasion, and metastasis. To …